<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35772782</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>11</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1521-0103</ISSN><JournalIssue CitedMedium="Internet"><Volume>384</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>The Journal of pharmacology and experimental therapeutics</Title><ISOAbbreviation>J Pharmacol Exp Ther</ISOAbbreviation></Journal><ArticleTitle>Exosomal miR-145 and miR-885 Regulate Thrombosis in COVID-19.</ArticleTitle><Pagination><StartPage>109</StartPage><EndPage>115</EndPage><MedlinePgn>109-115</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1124/jpet.122.001209</ELocationID><Abstract><AbstractText>We hypothesized that exosomal microRNAs could be implied in the pathogenesis of thromboembolic complications in coronavirus disease 2019 (COVID-19). We isolated circulating exosomes from patients with COVID-19, and then we divided our population in two arms based on the D-dimer level on hospital admission. We observed that exosomal miR-145 and miR-885 significantly correlate with D-dimer levels. Moreover, we demonstrate that human endothelial cells express the main cofactors needed for the internalization of the "Severe acute respiratory syndrome coronavirus 2" (SARS-CoV-2), including angiotensin converting enzyme 2, transmembrane protease serine 2, and CD-147. Interestingly, human endothelial cells treated with serum from COVID-19 patients release significantly less miR-145 and miR-885, exhibit increased apoptosis, and display significantly impaired angiogenetic properties compared with cells treated with non-COVID-19 serum. Taken together, our data indicate that exosomal miR-145 and miR-885 are essential in modulating thromboembolic events in COVID-19. SIGNIFICANCE STATEMENT: This work demonstrates for the first time that two specific microRNAs (namely miR-145 and miR-885) contained in circulating exosomes are functionally involved in thromboembolic events in COVID-19. These findings are especially relevant to the general audience when considering the emerging prominence of post-acute sequelae of COVID-19 systemic manifestations known as Long COVID.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 by The American Society for Pharmacology and Experimental Therapeutics.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gambardella</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medicine, Wilf Family Cardiovascular Research Institute (J.G., U.K., S.S.J., X.W., P.Mo.) and Department of Molecular Pharmacology, Einstein-Sinai Diabetes Research Center (ES-DRC), Institute for Neuroimmunology and Inflammation (INI), Fleischer Institute for Diabetes and Metabolism (FIDAM), Einstein Institute for Aging Research (G.S.), Albert Einstein College of Medicine, New York City, New York; Department of Advanced Biomedical Sciences, International Translational Research and Medical Education (ITME) Consortium, "Federico II" University, Naples, Italy (J.G., D.S., G.S.); Department of Advanced Medical and Surgical Sciences (C.S., R.M., P. Ma., G.P.), and Department of Mental and Physical Health and Preventive Medicine (P.Ma.) University of Campania, Naples, Italy; Infectious Disease Unit, "Sant'Anna and San Sebastiano" Hospital, Caserta, Italy (V.M.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kansakar</LastName><ForeName>Urna</ForeName><Initials>U</Initials><Identifier Source="ORCID">0000-0001-5847-0521</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Wilf Family Cardiovascular Research Institute (J.G., U.K., S.S.J., X.W., P.Mo.) and Department of Molecular Pharmacology, Einstein-Sinai Diabetes Research Center (ES-DRC), Institute for Neuroimmunology and Inflammation (INI), Fleischer Institute for Diabetes and Metabolism (FIDAM), Einstein Institute for Aging Research (G.S.), Albert Einstein College of Medicine, New York City, New York; Department of Advanced Biomedical Sciences, International Translational Research and Medical Education (ITME) Consortium, "Federico II" University, Naples, Italy (J.G., D.S., G.S.); Department of Advanced Medical and Surgical Sciences (C.S., R.M., P. Ma., G.P.), and Department of Mental and Physical Health and Preventive Medicine (P.Ma.) University of Campania, Naples, Italy; Infectious Disease Unit, "Sant'Anna and San Sebastiano" Hospital, Caserta, Italy (V.M.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sardu</LastName><ForeName>Celestino</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medicine, Wilf Family Cardiovascular Research Institute (J.G., U.K., S.S.J., X.W., P.Mo.) and Department of Molecular Pharmacology, Einstein-Sinai Diabetes Research Center (ES-DRC), Institute for Neuroimmunology and Inflammation (INI), Fleischer Institute for Diabetes and Metabolism (FIDAM), Einstein Institute for Aging Research (G.S.), Albert Einstein College of Medicine, New York City, New York; Department of Advanced Biomedical Sciences, International Translational Research and Medical Education (ITME) Consortium, "Federico II" University, Naples, Italy (J.G., D.S., G.S.); Department of Advanced Medical and Surgical Sciences (C.S., R.M., P. Ma., G.P.), and Department of Mental and Physical Health and Preventive Medicine (P.Ma.) University of Campania, Naples, Italy; Infectious Disease Unit, "Sant'Anna and San Sebastiano" Hospital, Caserta, Italy (V.M.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Messina</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Medicine, Wilf Family Cardiovascular Research Institute (J.G., U.K., S.S.J., X.W., P.Mo.) and Department of Molecular Pharmacology, Einstein-Sinai Diabetes Research Center (ES-DRC), Institute for Neuroimmunology and Inflammation (INI), Fleischer Institute for Diabetes and Metabolism (FIDAM), Einstein Institute for Aging Research (G.S.), Albert Einstein College of Medicine, New York City, New York; Department of Advanced Biomedical Sciences, International Translational Research and Medical Education (ITME) Consortium, "Federico II" University, Naples, Italy (J.G., D.S., G.S.); Department of Advanced Medical and Surgical Sciences (C.S., R.M., P. Ma., G.P.), and Department of Mental and Physical Health and Preventive Medicine (P.Ma.) University of Campania, Naples, Italy; Infectious Disease Unit, "Sant'Anna and San Sebastiano" Hospital, Caserta, Italy (V.M.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jankauskas</LastName><ForeName>Stanislovas S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Medicine, Wilf Family Cardiovascular Research Institute (J.G., U.K., S.S.J., X.W., P.Mo.) and Department of Molecular Pharmacology, Einstein-Sinai Diabetes Research Center (ES-DRC), Institute for Neuroimmunology and Inflammation (INI), Fleischer Institute for Diabetes and Metabolism (FIDAM), Einstein Institute for Aging Research (G.S.), Albert Einstein College of Medicine, New York City, New York; Department of Advanced Biomedical Sciences, International Translational Research and Medical Education (ITME) Consortium, "Federico II" University, Naples, Italy (J.G., D.S., G.S.); Department of Advanced Medical and Surgical Sciences (C.S., R.M., P. Ma., G.P.), and Department of Mental and Physical Health and Preventive Medicine (P.Ma.) University of Campania, Naples, Italy; Infectious Disease Unit, "Sant'Anna and San Sebastiano" Hospital, Caserta, Italy (V.M.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marfella</LastName><ForeName>Raffaele</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Medicine, Wilf Family Cardiovascular Research Institute (J.G., U.K., S.S.J., X.W., P.Mo.) and Department of Molecular Pharmacology, Einstein-Sinai Diabetes Research Center (ES-DRC), Institute for Neuroimmunology and Inflammation (INI), Fleischer Institute for Diabetes and Metabolism (FIDAM), Einstein Institute for Aging Research (G.S.), Albert Einstein College of Medicine, New York City, New York; Department of Advanced Biomedical Sciences, International Translational Research and Medical Education (ITME) Consortium, "Federico II" University, Naples, Italy (J.G., D.S., G.S.); Department of Advanced Medical and Surgical Sciences (C.S., R.M., P. Ma., G.P.), and Department of Mental and Physical Health and Preventive Medicine (P.Ma.) University of Campania, Naples, Italy; Infectious Disease Unit, "Sant'Anna and San Sebastiano" Hospital, Caserta, Italy (V.M.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maggi</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medicine, Wilf Family Cardiovascular Research Institute (J.G., U.K., S.S.J., X.W., P.Mo.) and Department of Molecular Pharmacology, Einstein-Sinai Diabetes Research Center (ES-DRC), Institute for Neuroimmunology and Inflammation (INI), Fleischer Institute for Diabetes and Metabolism (FIDAM), Einstein Institute for Aging Research (G.S.), Albert Einstein College of Medicine, New York City, New York; Department of Advanced Biomedical Sciences, International Translational Research and Medical Education (ITME) Consortium, "Federico II" University, Naples, Italy (J.G., D.S., G.S.); Department of Advanced Medical and Surgical Sciences (C.S., R.M., P. Ma., G.P.), and Department of Mental and Physical Health and Preventive Medicine (P.Ma.) University of Campania, Naples, Italy; Infectious Disease Unit, "Sant'Anna and San Sebastiano" Hospital, Caserta, Italy (V.M.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xujun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Medicine, Wilf Family Cardiovascular Research Institute (J.G., U.K., S.S.J., X.W., P.Mo.) and Department of Molecular Pharmacology, Einstein-Sinai Diabetes Research Center (ES-DRC), Institute for Neuroimmunology and Inflammation (INI), Fleischer Institute for Diabetes and Metabolism (FIDAM), Einstein Institute for Aging Research (G.S.), Albert Einstein College of Medicine, New York City, New York; Department of Advanced Biomedical Sciences, International Translational Research and Medical Education (ITME) Consortium, "Federico II" University, Naples, Italy (J.G., D.S., G.S.); Department of Advanced Medical and Surgical Sciences (C.S., R.M., P. Ma., G.P.), and Department of Mental and Physical Health and Preventive Medicine (P.Ma.) University of Campania, Naples, Italy; Infectious Disease Unit, "Sant'Anna and San Sebastiano" Hospital, Caserta, Italy (V.M.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mone</LastName><ForeName>Pasquale</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medicine, Wilf Family Cardiovascular Research Institute (J.G., U.K., S.S.J., X.W., P.Mo.) and Department of Molecular Pharmacology, Einstein-Sinai Diabetes Research Center (ES-DRC), Institute for Neuroimmunology and Inflammation (INI), Fleischer Institute for Diabetes and Metabolism (FIDAM), Einstein Institute for Aging Research (G.S.), Albert Einstein College of Medicine, New York City, New York; Department of Advanced Biomedical Sciences, International Translational Research and Medical Education (ITME) Consortium, "Federico II" University, Naples, Italy (J.G., D.S., G.S.); Department of Advanced Medical and Surgical Sciences (C.S., R.M., P. Ma., G.P.), and Department of Mental and Physical Health and Preventive Medicine (P.Ma.) University of Campania, Naples, Italy; Infectious Disease Unit, "Sant'Anna and San Sebastiano" Hospital, Caserta, Italy (V.M.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paolisso</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medicine, Wilf Family Cardiovascular Research Institute (J.G., U.K., S.S.J., X.W., P.Mo.) and Department of Molecular Pharmacology, Einstein-Sinai Diabetes Research Center (ES-DRC), Institute for Neuroimmunology and Inflammation (INI), Fleischer Institute for Diabetes and Metabolism (FIDAM), Einstein Institute for Aging Research (G.S.), Albert Einstein College of Medicine, New York City, New York; Department of Advanced Biomedical Sciences, International Translational Research and Medical Education (ITME) Consortium, "Federico II" University, Naples, Italy (J.G., D.S., G.S.); Department of Advanced Medical and Surgical Sciences (C.S., R.M., P. Ma., G.P.), and Department of Mental and Physical Health and Preventive Medicine (P.Ma.) University of Campania, Naples, Italy; Infectious Disease Unit, "Sant'Anna and San Sebastiano" Hospital, Caserta, Italy (V.M.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sorriento</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medicine, Wilf Family Cardiovascular Research Institute (J.G., U.K., S.S.J., X.W., P.Mo.) and Department of Molecular Pharmacology, Einstein-Sinai Diabetes Research Center (ES-DRC), Institute for Neuroimmunology and Inflammation (INI), Fleischer Institute for Diabetes and Metabolism (FIDAM), Einstein Institute for Aging Research (G.S.), Albert Einstein College of Medicine, New York City, New York; Department of Advanced Biomedical Sciences, International Translational Research and Medical Education (ITME) Consortium, "Federico II" University, Naples, Italy (J.G., D.S., G.S.); Department of Advanced Medical and Surgical Sciences (C.S., R.M., P. Ma., G.P.), and Department of Mental and Physical Health and Preventive Medicine (P.Ma.) University of Campania, Naples, Italy; Infectious Disease Unit, "Sant'Anna and San Sebastiano" Hospital, Caserta, Italy (V.M.) daniela.sorriento@unina.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santulli</LastName><ForeName>Gaetano</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-7231-375X</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Wilf Family Cardiovascular Research Institute (J.G., U.K., S.S.J., X.W., P.Mo.) and Department of Molecular Pharmacology, Einstein-Sinai Diabetes Research Center (ES-DRC), Institute for Neuroimmunology and Inflammation (INI), Fleischer Institute for Diabetes and Metabolism (FIDAM), Einstein Institute for Aging Research (G.S.), Albert Einstein College of Medicine, New York City, New York; Department of Advanced Biomedical Sciences, International Translational Research and Medical Education (ITME) Consortium, "Federico II" University, Naples, Italy (J.G., D.S., G.S.); Department of Advanced Medical and Surgical Sciences (C.S., R.M., P. Ma., G.P.), and Department of Mental and Physical Health and Preventive Medicine (P.Ma.) University of Campania, Naples, Italy; Infectious Disease Unit, "Sant'Anna and San Sebastiano" Hospital, Caserta, Italy (V.M.).</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 DK123259</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK033823</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL159062</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL146691</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 HL144456</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Pharmacol Exp Ther</MedlineTA><NlmUniqueID>0376362</NlmUniqueID><ISSNLinking>0022-3565</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C541010">MIRN145 microRNA, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C574934">MIRN885 microRNA, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042783" MajorTopicYN="N">Endothelial Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013927" MajorTopicYN="Y">Thrombosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055354" MajorTopicYN="Y">Exosomes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>30</Day><Hour>20</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35772782</ArticleId><ArticleId IdType="pmc">PMC9827505</ArticleId><ArticleId IdType="doi">10.1124/jpet.122.001209</ArticleId><ArticleId IdType="pii">jpet.122.001209</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Adebayo AVarzideh FWilson SGambardella JEacobacci MJankauskas SSDonkor KKansakar UTrimarco VMone P, et al. (2021) l-Arginine and COVID-19: an update. Nutrients 13:3951.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8619186</ArticleId><ArticleId IdType="pubmed">34836206</ArticleId></ArticleIdList></Reference><Reference><Citation>Amini-Farsani Z, Yadollahi-Farsani M, Arab S, Forouzanfar F, Yadollahi M, Asgharzade S (2021) Prediction and analysis of microRNAs involved in COVID-19 inflammatory processes associated with the NF-kB and JAK/STAT signaling pathways. Int Immunopharmacol 100:108071.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8378592</ArticleId><ArticleId IdType="pubmed">34482267</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoniou KMVasarmidi ERussell AMAndrejak CCrestani BDelcroix MDinh-Xuan ATPoletti VSverzellati NVitacca M, et al. (2022) European respiratory society statement on long COVID-19 follow-up. Eur Respir J DOI: 10.1183/13993003.02174-2021 [published ahead of print].</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9349784</ArticleId><ArticleId IdType="pubmed">35144991</ArticleId></ArticleIdList></Reference><Reference><Citation>Basu A, Agwu JC, Barlow N, Lee B (2021) Hypertension is the major predictor of poor outcomes among inpatients with COVID-19 infection in the UK: a retrospective cohort study. BMJ Open 11:e047561.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8238530</ArticleId><ArticleId IdType="pubmed">34172549</ArticleId></ArticleIdList></Reference><Reference><Citation>Battaglia RAlonzo RPennisi CCaponnetto AFerrara CStella MBarbagallo CBarbagallo DRagusa MPurrello M, et al. (2021) MicroRNA-mediated regulation of the virus cycle and pathogenesis in the SARS-CoV-2 disease. Int J Mol Sci 22:13192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8715670</ArticleId><ArticleId IdType="pubmed">34947989</ArticleId></ArticleIdList></Reference><Reference><Citation>Bikdeli BMadhavan MVJimenez DChuich TDreyfus IDriggin ENigoghossian CAgeno WMadjid MGuo Y, et al. ; Global COVID-19 Thrombosis Collaborative Group, Endorsed by the ISTH, NATF, ESVM, and the IUA, Supported by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function (2020) COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J Am Coll Cardiol 75:2950&#x2013;2973.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7164881</ArticleId><ArticleId IdType="pubmed">32311448</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xc7;alica Utku A, Budak G, Karabay O, G&#xfc;&#xe7;l&#xfc; E, Okan HD, Vatan A (2020) Main symptoms in patients presenting in the COVID-19 period. Scott Med J 65:127&#x2013;132.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8685469</ArticleId><ArticleId IdType="pubmed">32807018</ArticleId></ArticleIdList></Reference><Reference><Citation>Cattadori G, Di Marco S, Baravelli M, Picozzi A, Ambrosio G (2022) Exercise training in post-COVID-19 patients: the need for a multifactorial protocol for a multifactorial pathophysiology. J Clin Med 11:2228.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9028177</ArticleId><ArticleId IdType="pubmed">35456321</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho O, Kim DW, Cheong JY (2021) Plasma exosomal miRNA levels after radiotherapy are associated with early progression and metastasis of cervical cancer: a pilot study. J Clin Med 10:2110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8153571</ArticleId><ArticleId IdType="pubmed">34068397</ArticleId></ArticleIdList></Reference><Reference><Citation>Comelli AViero GBettini GNobili ATettamanti MGalbussera AAMuscatello AMantero MCanetta CMartinelli Boneschi F, et al. (2022) Patient-reported symptoms and sequelae 12 months after COVID-19 in hospitalized adults: a multicenter long-term follow-up study. Front Med (Lausanne) 9:834354.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8981315</ArticleId><ArticleId IdType="pubmed">35391879</ArticleId></ArticleIdList></Reference><Reference><Citation>Conte G, Cei M, Evangelista I, Colombo A, Vitale J, Mazzone A, Mumoli N (2021) The meaning of D-dimer value in Covid-19. Clin Appl Thromb Hemost 27:10760296211017668.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8142231</ArticleId><ArticleId IdType="pubmed">34011194</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P (2021) Long covid-mechanisms, risk factors, and management. BMJ 374:n1648.</Citation><ArticleIdList><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Cryer MJ, Farhan S, Kaufmann CC, J&#xe4;ger B, Garg A, Krishnan P, Mehran R, Huber K (2022) Prothrombotic milieu, thrombotic events and prophylactic anticoagulation in hospitalized COVID-19 positive patients: a review. Clin Appl Thromb Hemost 28:10760296221074353.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8793375</ArticleId><ArticleId IdType="pubmed">35068227</ArticleId></ArticleIdList></Reference><Reference><Citation>Dash S, Dash C, Pandhare J (2021) Therapeutic significance of microRNA-mediated regulation of PARP-1 in SARS-CoV-2 infection. Noncoding RNA 7:60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8544662</ArticleId><ArticleId IdType="pubmed">34698261</ArticleId></ArticleIdList></Reference><Reference><Citation>Davido B, Seang S, Tubiana R, de Truchis P (2020) Post-COVID-19 chronic symptoms: a postinfectious entity? Clin Microbiol Infect 26:1448&#x2013;1449.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7376333</ArticleId><ArticleId IdType="pubmed">32712242</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai AD, Lavelle M, Boursiquot BC, Wan EY (2022) Long-term complications of COVID-19. Am J Physiol Cell Physiol 322:C1&#x2013;C11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8721906</ArticleId><ArticleId IdType="pubmed">34817268</ArticleId></ArticleIdList></Reference><Reference><Citation>Dridi HSantulli GGambardella JJankauskas SSYuan QYang JReiken SWang XWronska ALiu X, et al. (2022) IP3 receptor orchestrates maladaptive vascular responses in heart failure. J Clin Invest 132:e152859.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8843748</ArticleId><ArticleId IdType="pubmed">35166236</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans JP, Liu SL (2021) Role of host factors in SARS-CoV-2 entry. J Biol Chem 297:100847.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8160279</ArticleId><ArticleId IdType="pubmed">34058196</ArticleId></ArticleIdList></Reference><Reference><Citation>Farr RJRootes CLRowntree LCNguyen THOHensen LKedzierski LCheng ACKedzierska KAu GGMarsh GA, et al. (2021) Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection. PLoS Pathog 17:e1009759.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8318295</ArticleId><ArticleId IdType="pubmed">34320031</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiorentino G, Coppola A, Izzo R, Annunziata A, Bernardo M, Lombardi A, Trimarco V, Santulli G, Trimarco B (2021) Effects of adding L-arginine orally to standard therapy in patients with COVID-19: a randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis. EClinicalMedicine 40:101125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8428476</ArticleId><ArticleId IdType="pubmed">34522871</ArticleId></ArticleIdList></Reference><Reference><Citation>Gambardella J, Coppola A, Izzo R, Fiorentino G, Trimarco B, Santulli G (2021) Role of endothelial miR-24 in COVID-19 cerebrovascular events. Crit Care 25:306.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8385482</ArticleId><ArticleId IdType="pubmed">34433473</ArticleId></ArticleIdList></Reference><Reference><Citation>Gambardella J, De Rosa M, Sorriento D, Prevete N, Fiordelisi A, Ciccarelli M, Trimarco B, De Luca N, Iaccarino G (2018) Parathyroid hormone causes endothelial dysfunction by inducing mitochondrial ROS and specific oxidative signal transduction modifications. Oxid Med Cell Longev 2018:9582319.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6313989</ArticleId><ArticleId IdType="pubmed">30662585</ArticleId></ArticleIdList></Reference><Reference><Citation>Gambardella J, Khondkar W, Morelli MB, Wang X, Santulli G, Trimarco V (2020) Arginine and endothelial function. Biomedicines 8:277.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7460461</ArticleId><ArticleId IdType="pubmed">32781796</ArticleId></ArticleIdList></Reference><Reference><Citation>Gambardella J, Santulli G (2021) What is linking COVID-19 and endothelial dysfunction? Updates on nanomedicine and bioengineering from the 2020 AHA Scientific Sessions. Eur Heart J Cardiovasc Pharmacother 7:e2&#x2013;e3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7799225</ArticleId><ArticleId IdType="pubmed">33377481</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh K, Ghosh K (2022) D-dimer: an analyte with increasing application in Covid-19 infection. Expert Rev Hematol 15:243&#x2013;251.</Citation><ArticleIdList><ArticleId IdType="pubmed">35262442</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu SXTyagi TJain KGu VWLee SHHwa JMKwan JMKrause DSLee AIHalene S, et al. (2021) Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation. Nat Rev Cardiol 18:194&#x2013;209.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7675396</ArticleId><ArticleId IdType="pubmed">33214651</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo TWang YJia JMao XStankiewicz EScandura GBurke EXu LMarzec JDavies CR, et al. (2021) The identification of plasma exosomal miR-423-3p as a potential predictive biomarker for prostate cancer castration-resistance development by plasma exosomal miRNA sequencing. Front Cell Dev Biol 8:602493.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7817948</ArticleId><ArticleId IdType="pubmed">33490068</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta AGonzalez-Rojas YJuarez ECrespo Casal MMoya JRodrigues Falci DSarkis ESolis JZheng HScott N, et al. ; COMET-ICE Investigators (2022) Effect of Sotrovimab on hospitalization or death among high-risk patients with mild to moderate COVID-19: a randomized clinical trial. JAMA 327:1236&#x2013;1246.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8922199</ArticleId><ArticleId IdType="pubmed">35285853</ArticleId></ArticleIdList></Reference><Reference><Citation>He X, Park S, Chen Y, Lee H (2021) Extracellular vesicle-associated miRNAs as a biomarker for lung cancer in liquid biopsy. Front Mol Biosci 8:630718.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7943919</ArticleId><ArticleId IdType="pubmed">33718435</ArticleId></ArticleIdList></Reference><Reference><Citation>Iacobucci G (2022) Covid-19: UK adds sore throat, headache, fatigue, and six other symptoms to official list. BMJ 377:o892.</Citation><ArticleIdList><ArticleId IdType="pubmed">35379691</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal FM, Lam K, Sounderajah V, Clarke JM, Ashrafian H, Darzi A (2021) Characteristics and predictors of acute and chronic post-COVID syndrome: a systematic review and meta-analysis. EClinicalMedicine 36:100899.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8141371</ArticleId><ArticleId IdType="pubmed">34036253</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaliszewski KDiakowska DNowak &#x141;Tokarczyk USroczy&#x144;ski MS&#x119;pek MDudek ASutkowska-St&#x119;pie&#x144; KKili&#x15b;-Pstrusi&#x144;ska KMatera-Witkiewicz A, et al. (2022) Assessment of gastrointestinal symptoms and dyspnea in patients hospitalized due to COVID-19: contribution to clinical course and mortality. J Clin Med 11:1821.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8999487</ArticleId><ArticleId IdType="pubmed">35407430</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur SP, Gupta V (2020) COVID-19 vaccine: a comprehensive status report. Virus Res 288:198114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7423510</ArticleId><ArticleId IdType="pubmed">32800805</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelliher SWeiss LCullivan SO&#x2019;Rourke EMurphy CAToolan SLennon &#xc1;Szklanna PBComer SPMacleod H, et al. (2022) Non-severe COVID-19 is associated with endothelial damage and hypercoagulability despite pharmacological thromboprophylaxis. J Thromb Haemost 20:1008&#x2013;1014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9305123</ArticleId><ArticleId IdType="pubmed">35102689</ArticleId></ArticleIdList></Reference><Reference><Citation>Lage SLAmaral EPHilligan KLLaidlaw ERupert ANamasivayan SRocco JGalindo FKellogg AKumar P, et al. (2022) Persistent oxidative stress and inflammasome activation in CD14highCD16- monocytes from COVID-19 patients. Front Immunol 12:799558.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8795739</ArticleId><ArticleId IdType="pubmed">35095880</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Li M, Wang M, Zhou Y, Chang J, Xian Y, Wang D, Mao L, Jin H, Hu B (2020) Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke Vasc Neurol 5:279&#x2013;284.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7371480</ArticleId><ArticleId IdType="pubmed">32616524</ArticleId></ArticleIdList></Reference><Reference><Citation>Libby P, Aikawa M, Jain MK (2006) Vascular endothelium and atherosclerosis. Handb Exp Pharmacol 176 Pt 2:285&#x2013;306.</Citation><ArticleIdList><ArticleId IdType="pubmed">16999230</ArticleId></ArticleIdList></Reference><Reference><Citation>Libby P, L&#xfc;scher T (2020) COVID-19 is, in the end, an endothelial disease. Eur Heart J 41:3038&#x2013;3044.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7470753</ArticleId><ArticleId IdType="pubmed">32882706</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Z, Wong A, Alam S (2022) Extraction of exosomes and exosomal miRNA from mesenchymal stem cells. Methods Mol Biol 2455:333&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pubmed">35213005</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukiw WJ (2021) microRNA heterogeneity, innate-immune defense and the efficacy of SARS-CoV-2 infection-a commentary. Noncoding RNA 7:37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8293307</ArticleId><ArticleId IdType="pubmed">34207055</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyu L, Li H, Chen C, Yu Y, Wang L, Yin S, Hu Y, Jiang S, Ye F, Zhou P (2022) Exosomal miRNA profiling is a potential screening route for non-functional pituitary adenoma. Front Cell Dev Biol 9:771354.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8804500</ArticleId><ArticleId IdType="pubmed">35118066</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmoudi A, Butler AE, Jamialahmadi T, Sahebkar A (2022) The role of exosomal miRNA in nonalcoholic fatty liver disease. J Cell Physiol 237:2078&#x2013;2094.</Citation><ArticleIdList><ArticleId IdType="pubmed">35137416</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;n-Fern&#xe1;ndez MAller RHeredia-Rodr&#xed;guez MG&#xf3;mez-S&#xe1;nchez EMart&#xed;nez-Paz PGonzalo-Benito HS&#xe1;nchez-de Prada LGorgojo &#xd3;Carnicero-Frutos ITamayo E, et al. (2021) Lipid peroxidation as a hallmark of severity in COVID-19 patients. Redox Biol 48:102181.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8572041</ArticleId><ArticleId IdType="pubmed">34768063</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Salazar B, Holwerda M, St&#xfc;dle C, Piragyte I, Mercader N, Engelhardt B, Rieben R, D&#xf6;ring Y (2022) COVID-19 and the vasculature: current aspects and long-term consequences. Front Cell Dev Biol 10:824851.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8887620</ArticleId><ArticleId IdType="pubmed">35242762</ArticleId></ArticleIdList></Reference><Reference><Citation>Matarese A, Gambardella J, Lombardi A, Wang X, Santulli G (2020a) miR-7 regulates GLP-1-mediated insulin release by targeting &#x3b2;-Arrestin 1. Cells 9:1621.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7407368</ArticleId><ArticleId IdType="pubmed">32640511</ArticleId></ArticleIdList></Reference><Reference><Citation>Matarese A, Gambardella J, Sardu C, Santulli G (2020b) miR-98 regulates TMPRSS2 expression in human endothelial cells: key implications for COVID-19. Biomedicines 8:462.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7693865</ArticleId><ArticleId IdType="pubmed">33143053</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesquida JCaballer ACortese LVila CKaradeniz UPagliazzi MZanoletti MPacheco APCastro PGarc&#xed;a-de-Acilu M, et al. ; HEMOCOVID-19 Consortium (2021) Peripheral microcirculatory alterations are associated with the severity of acute respiratory distress syndrome in COVID-19 patients admitted to intermediate respiratory and intensive care units. Crit Care 25:381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8575160</ArticleId><ArticleId IdType="pubmed">34749792</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen MManoharan LElkheir NCheng VDagens AHastie CO&#x2019;Hara MSuett JDahmash DBugaeva P, et al. (2021) Characterising long COVID: a living systematic review. BMJ Glob Health 6:e005427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Mone P, Gambardella J, Wang X, Jankauskas SS, Matarese A, Santulli G (2021) miR-24 targets the transmembrane glycoprotein neuropilin-1 in human brain microvascular endothelial cells. Noncoding RNA 7:9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7931075</ArticleId><ArticleId IdType="pubmed">33540664</ArticleId></ArticleIdList></Reference><Reference><Citation>Mone P, Izzo R, Marazzi G, Manzi MV, Gallo P, Campolongo G, Cacciotti L, Tartaglia D, Caminiti G, Varzideh F, Santulli G, Trimarco V (2022) L-Arginine enhances the effects of cardiac rehabilitation on physical performance: new insights for managing cardiovascular patients during the COVID-19 pandemic. J Pharmacol Exp Ther 381:197&#x2013;203.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9190231</ArticleId><ArticleId IdType="pubmed">35339987</ArticleId></ArticleIdList></Reference><Reference><Citation>Morelli MB, Shu J, Sardu C, Matarese A, Santulli G (2019) Cardiosomal microRNAs are essential in post-infarction myofibroblast phenoconversion. Int J Mol Sci 21:201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6982041</ArticleId><ArticleId IdType="pubmed">31892162</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez OMerino ELeon-Ramirez JMAndres MRamos JMArenas-Jim&#xe9;nez JAsensio SSanchez RRuiz-Torregrosa PGalan I, et al. ; COVID19-ALC research group (2021) Post-acute COVID-19 syndrome. Incidence and risk factors: a Mediterranean cohort study. J Infect 82:378&#x2013;383.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Mui LW, Lau JF, Lee HK (2021) Thromboembolic complications of COVID-19. Emerg Radiol 28:423&#x2013;429.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7647885</ArticleId><ArticleId IdType="pubmed">33159219</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray EGoodfellow HBindman JBlandford ABradbury KChaudhry TFernandez-Reyes DGomes MHamilton FLHeightman M, et al. (2022) Development, deployment and evaluation of digitally enabled, remote, supported rehabilitation for people with long COVID-19 (Living With COVID-19 Recovery): protocol for a mixed-methods study. BMJ Open 12:e057408.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8822541</ArticleId><ArticleId IdType="pubmed">35131836</ArticleId></ArticleIdList></Reference><Reference><Citation>N&#xe4;rhi FMoonesinghe SRShenkin SDDrake TMMulholland RHDonegan CDunning JFairfield CJGirvan MHardwick HE, et al. ; ISARIC4C investigators (2022) Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study. Lancet Digit Health 4:e220&#x2013;e234.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8940185</ArticleId><ArticleId IdType="pubmed">35337642</ArticleId></ArticleIdList></Reference><Reference><Citation>Naro&#x17c;na M, Rubi&#x15b; B (2021) Anti-SARS-CoV-2 strategies and the potential role of miRNA in the assessment of COVID-19 morbidity, recurrence, and therapy. Int J Mol Sci 22:8663.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8395427</ArticleId><ArticleId IdType="pubmed">34445368</ArticleId></ArticleIdList></Reference><Reference><Citation>Ning W, Li S, Yang W, Yang B, Xin C, Ping X, Huang C, Gu Y, Guo L (2021) Blocking exosomal miRNA-153-3p derived from bone marrow mesenchymal stem cells ameliorates hypoxia-induced myocardial and microvascular damage by targeting the ANGPT1-mediated VEGF/PI3k/Akt/eNOS pathway. Cell Signal 77:109812.</Citation><ArticleIdList><ArticleId IdType="pubmed">33164880</ArticleId></ArticleIdList></Reference><Reference><Citation>Oikonomou ESouvaliotis NLampsas SSiasos GPoulakou GTheofilis PPapaioannou TGHaidich ABTsaousi GNtousopoulos V, et al. (2022) Endothelial dysfunction in acute and long standing COVID-19: a prospective cohort study. Vascul Pharmacol 144:106975.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893931</ArticleId><ArticleId IdType="pubmed">35248780</ArticleId></ArticleIdList></Reference><Reference><Citation>Otifi HM, Adiga BK (2022) Endothelial dysfunction in Covid-19 infection. Am J Med Sci 363:281&#x2013;287.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8802031</ArticleId><ArticleId IdType="pubmed">35093394</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozen M, Yilmaz A, Cakmak V, Beyoglu R, Oskay A, Seyit M, Senol H (2021) D-dimer as a potential biomarker for disease severity in COVID-19. Am J Emerg Med 40:55&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7837156</ArticleId><ArticleId IdType="pubmed">33348224</ArticleId></ArticleIdList></Reference><Reference><Citation>Perea Polak A, Romero Madrid B, PP, Alvarez G, Pilar L, -Moyano E (2021) Complement-mediated thrombogenic vasculopathy in COVID-19. Int J Dermatol 60:229&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7753700</ArticleId><ArticleId IdType="pubmed">33259066</ArticleId></ArticleIdList></Reference><Reference><Citation>Plowman T, Lagos D (2021) Non-coding RNAs in COVID-19: emerging insights and current questions. Noncoding RNA 7:54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8482139</ArticleId><ArticleId IdType="pubmed">34564316</ArticleId></ArticleIdList></Reference><Reference><Citation>Poudel A, Poudel Y, Adhikari A, Aryal BB, Dangol D, Bajracharya T, Maharjan A, Gautam R (2021) D-dimer as a biomarker for assessment of COVID-19 prognosis: D-dimer levels on admission and its role in predicting disease outcome in hospitalized patients with COVID-19. PLoS One 16:e0256744.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8389366</ArticleId><ArticleId IdType="pubmed">34437642</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin ZLiu FBlair RWang CYang HMudd JCurrey JMIwanaga NHe JMi R, et al. (2021) Endothelial cell infection and dysfunction, immune activation in severe COVID-19. Theranostics 11:8076&#x2013;8091.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8315069</ArticleId><ArticleId IdType="pubmed">34335981</ArticleId></ArticleIdList></Reference><Reference><Citation>Robineau OWiernik ELemogne Cde Lamballerie XNinove LBlanch&#xe9; HDeleuze JFRibet CKab SGoldberg M, et al. (2022) Persistent symptoms after the first wave of COVID-19 in relation to SARS-CoV-2 serology and experience of acute symptoms: a nested survey in a population-based cohort. Lancet Reg Health Eur 17:100363.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9005155</ArticleId><ArticleId IdType="pubmed">35434687</ArticleId></ArticleIdList></Reference><Reference><Citation>Robles JP, Zamora M, Adan-Castro E, Siqueiros-Marquez L, Martinez de la Escalera G, Clapp C (2022) The spike protein of SARS-CoV-2 induces endothelial inflammation through integrin &#x3b1;5&#x3b2;1 and NF-&#x3ba;B signaling. J Biol Chem 298:101695.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8820157</ArticleId><ArticleId IdType="pubmed">35143839</ArticleId></ArticleIdList></Reference><Reference><Citation>Rostami M, Mansouritorghabeh H (2020) D-dimer level in COVID-19 infection: a systematic review. Expert Rev Hematol 13:1265&#x2013;1275.</Citation><ArticleIdList><ArticleId IdType="pubmed">32997543</ArticleId></ArticleIdList></Reference><Reference><Citation>Saha C, Laha S, Chatterjee R, Bhattacharyya NP (2021) Co-regulation of protein coding genes by transcription factor and long non-coding RNA in SARS-CoV-2 infected cells: an in silico analysis. Noncoding RNA 7:74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8708613</ArticleId><ArticleId IdType="pubmed">34940755</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahu AJha PKPrabhakar ASingh HDGupta NChatterjee TTyagi TSharma SKumari BSingh S, et al. (2017) MicroRNA-145 impedes thrombus formation via targeting tissue factor in venous thrombosis. EBioMedicine 26:175&#x2013;186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5832640</ArticleId><ArticleId IdType="pubmed">29217135</ArticleId></ArticleIdList></Reference><Reference><Citation>Santulli G (2016) MicroRNA: From Molecular Biology to Clinical Practice, Springer Nature, New York.</Citation></Reference><Reference><Citation>Santulli GBasilicata MFDe Simone MDel Giudice CAnastasio ASorriento DSaviano MDel Gatto ATrimarco BPedone C, et al. (2011) Evaluation of the anti-angiogenic properties of the new selective &#x3b1;V&#x3b2;3 integrin antagonist RGDechiHCit. J Transl Med 9:7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3027097</ArticleId><ArticleId IdType="pubmed">21232121</ArticleId></ArticleIdList></Reference><Reference><Citation>Sardu C, Gambardella J, Morelli MB, Wang X, Marfella R, Santulli G (2020) Hypertension, thrombosis, kidney failure, and diabetes: is COVID-19 an endothelial disease? a comprehensive evaluation of clinical and basic evidence. J Clin Med 9:1417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7290769</ArticleId><ArticleId IdType="pubmed">32403217</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmaier AAPajares Hurtado GMManickas-Hill ZJSack KDChen SMBhambhani VQuadir JNath AKCollier AYNgo D, et al. ; MGH COVID-19 Collection and Processing Team (2021) Tie2 activation protects against prothrombotic endothelial dysfunction in COVID-19. JCI Insight 6:e151527.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8564889</ArticleId><ArticleId IdType="pubmed">34506304</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith MP (2022) Estimating total morbidity burden of COVID-19: relative importance of death and disability. J Clin Epidemiol 142:54&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8547965</ArticleId><ArticleId IdType="pubmed">34715312</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorriento D, Campanile A, Santulli G, Leggiero E, Pastore L, Trimarco B, Iaccarino G (2009) A new synthetic protein, TAT-RH, inhibits tumor growth through the regulation of NFkappaB activity. Mol Cancer 8:97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2780391</ArticleId><ArticleId IdType="pubmed">19900276</ArticleId></ArticleIdList></Reference><Reference><Citation>Soto ME, Guarner-Lans V, D&#xed;az-D&#xed;az E, Manzano-Pech L, Palacios-Chavarr&#xed;a A, Valdez-V&#xe1;zquez RR, Aisa-&#xc1;lvarez A, Saucedo-Orozco H, P&#xe9;rez-Torres I (2022) Hyperglycemia and loss of redox homeostasis in COVID-19 patients. Cells 11:932.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8946177</ArticleId><ArticleId IdType="pubmed">35326383</ArticleId></ArticleIdList></Reference><Reference><Citation>Stasi C, Fallani S, Voller F, Silvestri C (2020) Treatment for COVID-19: an overview. Eur J Pharmacol 889:173644.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7548059</ArticleId><ArticleId IdType="pubmed">33053381</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang XH, Gambardella J, Jankauskas S, Wang X, Santulli G, Gudas LJ, Levi R (2021) A retinoic acid receptor &#x3b2;2 agonist improves cardiac function in a heart failure model. J Pharmacol Exp Ther 379:182&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8626778</ArticleId><ArticleId IdType="pubmed">34389654</ArticleId></ArticleIdList></Reference><Reference><Citation>Teuwen LA, Geldhof V, Pasut A, Carmeliet P (2020) COVID-19: the vasculature unleashed. Nat Rev Immunol 20:389&#x2013;391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7240244</ArticleId><ArticleId IdType="pubmed">32439870</ArticleId></ArticleIdList></Reference><Reference><Citation>Thye AY, Law JW, Tan LT, Pusparajah P, Ser HL, Thurairajasingam S, Letchumanan V, Lee LH (2022) Psychological symptoms in COVID-19 patients: insights into pathophysiology and risk factors of long COVID-19. Biology (Basel) 11:61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8773222</ArticleId><ArticleId IdType="pubmed">35053059</ArticleId></ArticleIdList></Reference><Reference><Citation>Tregoning JS, Brown ES, Cheeseman HM, Flight KE, Higham SL, Lemm NM, Pierce BF, Stirling DC, Wang Z, Pollock KM (2020) Vaccines for COVID-19. Clin Exp Immunol 202:162&#x2013;192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7597597</ArticleId><ArticleId IdType="pubmed">32935331</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueta E, Tsutsumi K, Kato H, Matsushita H, Shiraha H, Fujii M, Matsumoto K, Horiguchi S, Okada H (2021) Extracellular vesicle-shuttled miRNAs as a diagnostic and prognostic biomarker and their potential roles in gallbladder cancer patients. Sci Rep 11:12298.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8192895</ArticleId><ArticleId IdType="pubmed">34112884</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulinici M, Covantev S, Wingfield-Digby J, Beloukas A, Mathioudakis AG, Corlateanu A (2021) Screening, diagnostic and prognostic tests for COVID-19: a comprehensive review. Life (Basel) 11:561.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8231764</ArticleId><ArticleId IdType="pubmed">34198591</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, Levi M, Hunt BJ (2022) Prevention and management of thrombosis in hospitalised patients with COVID-19 pneumonia. Lancet Respir Med 10:214&#x2013;220.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8616572</ArticleId><ArticleId IdType="pubmed">34838161</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang DHuang TRen TLiu QZhou ZGe LChen ZLiu JNie HMa W, et al. (2022) Identification of blood exosomal miRNA-1246, miRNA-150-5p, miRNA-5787 and miRNA-8069 as sensitive biomarkers for hepatitis B virus infection. Clin Lab 68.</Citation><ArticleIdList><ArticleId IdType="pubmed">35142198</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang KChen WZhang ZDeng YLian JQDu PWei DZhang YSun XXGong L, et al. (2020a) CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells. Signal Transduct Target Ther 5:283.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7714896</ArticleId><ArticleId IdType="pubmed">33277466</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Morelli MB, Matarese A, Sardu C, Santulli G (2020b) Cardiomyocyte-derived exosomal microRNA-92a mediates post-ischemic myofibroblast activation both in vitro and ex vivo. ESC Heart Fail 7:284&#x2013;288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7083461</ArticleId><ArticleId IdType="pubmed">31981320</ArticleId></ArticleIdList></Reference><Reference><Citation>Weerakkody S, Arina P, Glenister J, Cottrell S, Boscaini-Gilroy G, Singer M, Montgomery HE (2022) Non-invasive respiratory support in the management of acute COVID-19 pneumonia: considerations for clinical practice and priorities for research. Lancet Respir Med 10:199&#x2013;213.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8577844</ArticleId><ArticleId IdType="pubmed">34767767</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M, Elliott J, Chadeau-Hyam M, Riley S, Darzi A, Cooke G, Ward H, Elliott P (2022) Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun 13:1957.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu KK, Thiagarajan P (1996) Role of endothelium in thrombosis and hemostasis. Annu Rev Med 47:315&#x2013;331.</Citation><ArticleIdList><ArticleId IdType="pubmed">8712785</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Z, Yang M, Lai CL (2021) Long COVID-19 syndrome: a comprehensive review of its effect on various organ systems and recommendation on rehabilitation plans. Biomedicines 9:966.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8394513</ArticleId><ArticleId IdType="pubmed">34440170</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C, Liu F, Liu W, Cao G, Liu J, Huang S, Zhu M, Tu C, Wang J, Xiong B (2021) Myocardial injury and risk factors for mortality in patients with COVID-19 pneumonia. Int J Cardiol 326:230&#x2013;236.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7510443</ArticleId><ArticleId IdType="pubmed">32979425</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin J, Wang S, Liu Y, Chen J, Li D, Xu T (2021) Coronary microvascular dysfunction pathophysiology in COVID-19. Microcirculation 28:e12718.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8236988</ArticleId><ArticleId IdType="pubmed">34013612</ArticleId></ArticleIdList></Reference><Reference><Citation>Ying W, Gao H, Dos Reis FCG, Bandyopadhyay G, Ofrecio JM, Luo Z, Ji Y, Jin Z, Ly C, Olefsky JM (2021) MiR-690, an exosomal-derived miRNA from M2-polarized macrophages, improves insulin sensitivity in obese mice. Cell Metab 33:781&#x2013;790.e5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8035248</ArticleId><ArticleId IdType="pubmed">33450179</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x17d;arkovi&#x107; NOrehovec BMilkovi&#x107; LBar&#x161;i&#x107; BTatzber FWonisch WTarle MKmet MMatai&#x107; AJakov&#x10d;evi&#x107; A, et al. (2021) Preliminary findings on the association of the lipid peroxidation product 4-hydroxynonenal with the lethal outcome of aggressive COVID-19. Antioxidants 10:1341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8472532</ArticleId><ArticleId IdType="pubmed">34572973</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang DCai GLiu KZhuang ZJia KPei SWang XWang HXu SCui C, et al. (2021a) Microglia exosomal miRNA-137 attenuates ischemic brain injury through targeting Notch1. Aging (Albany NY) 13:4079&#x2013;4095.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7906161</ArticleId><ArticleId IdType="pubmed">33461167</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z, Zhang Z (2020) D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. J Thromb Haemost 18:1324&#x2013;1329.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7264730</ArticleId><ArticleId IdType="pubmed">32306492</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T, Guo J, Gu J, Wang Z, Wang G, Li H, Wang J (2019) Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments. Oncol Rep 41:279&#x2013;291.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6278419</ArticleId><ArticleId IdType="pubmed">30542696</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang XBHu LMing QWei XJZhang ZYChen LDWang MHYao WZHuang QFYe ZQ, et al. (2021b) Risk factors for mortality of coronavirus disease-2019 (COVID-19) patients in two centers of Hubei province, China: a retrospective analysis. PLoS One 16:e0246030.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7842894</ArticleId><ArticleId IdType="pubmed">33507974</ArticleId></ArticleIdList></Reference><Reference><Citation>Zipeto D, Palmeira JDF, Arga&#xf1;araz GA, Arga&#xf1;araz ER (2020) ACE2/ADAM17/TMPRSS2 interplay may be the main risk factor for COVID-19. Front Immunol 11:576745.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7575774</ArticleId><ArticleId IdType="pubmed">33117379</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>